Novartis swine flu vaccine approved in Germany

ZURICH, Nov 5 (Reuters) - Germany has approved Novartis AG's (NOVN.VX: 行情) H1N1 swin flu vaccine Celtura, the Swiss drugmaker said on Thursday.

Novartis, whose other H1N1 vaccine, Focetria, recently received backing in Switzerland, said it would continue to seek registration in other major countries including Japan and Switzerland.

Celtura can be used to vaccinate people from six months and older against the H1N1 virus.

Novartis has already started to ship doses of its vaccines Fluvirin to the US, and Focetria to countries around the world.

The US Food and Drug Administration approved the Fluvirin in September, while the EMEA approved the Focetria vaccine on September 29, 2009.

(Reporting by Katie Reid)